Does ZANUBRUTINIB Cause Basal cell carcinoma? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Basal cell carcinoma have been filed in association with ZANUBRUTINIB (BRUKINSA). This represents 0.3% of all adverse event reports for ZANUBRUTINIB.
8
Reports of Basal cell carcinoma with ZANUBRUTINIB
0.3%
of all ZANUBRUTINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From ZANUBRUTINIB?
Of the 8 reports, 1 (12.5%) resulted in death, 3 (37.5%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZANUBRUTINIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ZANUBRUTINIB Cause?
Off label use (376)
Disease progression (224)
Contusion (165)
Myelosuppression (147)
Fatigue (146)
Rash (134)
Death (120)
White blood cell count decreased (119)
Platelet count decreased (112)
Anaemia (102)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which ZANUBRUTINIB Alternatives Have Lower Basal cell carcinoma Risk?
ZANUBRUTINIB vs ZAVEGEPANT
ZANUBRUTINIB vs ZEAXANTHIN
ZANUBRUTINIB vs ZELBORAF
ZANUBRUTINIB vs ZEMPLAR
ZANUBRUTINIB vs ZENATANE